Urological cancers have obtained much attention in recent years due to their mortality and
morbidity. The most common and malignant tumor of urological cancers is prostate cancer …

The continuous remodeling of the tumor microenvironment (TME) during prostate
tumorigenesis is emerging as a critical event that facilitates cancer growth, progression and …

The c-Myc signaling is a new emerging target in cancer therapy. Activation of c-Myc
signaling leads to cancer growth and invasion in vitro and in vivo. The stability of c-Myc can …

Laetiporus sulphureus is an edible and medicinal mushroom. A sulfated galactoglucan
(SPS) was isolated by the papain method. Polysaccharides (PS) were isolated by hot water …

The transcription factor Friend leukemia virus integration 1 (Fli-1) belonging to the E26
Transformation-Specific (ETS) transcription factor family is not only expressed in normal …

Prostate cancer is a prevalent malignancy among men globally, and androgen deprivation
therapy is the conventional first-line treatment for metastatic prostate cancer. While …

Prostate cancer (PCa) is today the second most common cancer in the world, with almost
400,000 deaths annually. Multiple factors are involved in the etiology of PCa, such as older …

Molecular heterogeneity in prostate cancer (PCa) is one of the key reasons underlying the
differing likelihoods of recurrence after surgical treatment in individual patients of the same …

Background Bone is the most common site of metastasis of prostate cancer (PCa). PCa
invasion leads to a disruption of osteogenic-osteolytic balance and causes abnormal bone …

Prostate cancer (PCa) accounts as the most common non-cutaneous disease affecting
males, and as the first cancer, for incidence, in male. With the introduction of the concept of …